Early Patient Access Treatment Use Protocol CA204-220

NCT02856438 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Elotuzumab
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]